Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Breast Neoplasms 13126Neoplasms 10474Carcinoma, Non-Small-Cell Lung 6863Prostatic Neoplasms 6265Colorectal Neoplasms 5940Lung Neoplasms 5097Multiple Myeloma 3573Pancreatic Neoplasms 3558Leukemia, Myeloid, Acute 3507Neoplasm Metastasis 3505Carcinoma, Hepatocellular 3269Ovarian Neoplasms 3166Melanoma 3138Stomach Neoplasms 3055Lymphoma 2982Head and Neck Neoplasms 2599Recurrence 2553Precursor Cell Lymphoblastic Leukemia-Lymphoma 2497Leukemia 2361Colonic Neoplasms 2327Brain Neoplasms 2308Lymphoma, Non-Hodgkin 2268Rectal Neoplasms 2190Uterine Cervical Neoplasms 2187Glioblastoma 2012Leukemia, Lymphocytic, Chronic, B-Cell 1992Carcinoma, Renal Cell 1912Squamous Cell Carcinoma of Head and Neck 1878Lymphoma, Follicular 1847Esophageal Neoplasms 1799

Interventions

thymoglobulin 1fludarabine phosphate 1fludarabine 1Whole-Body Irradiation 1Stem Cell Transplantation 1Sirolimus 1Mycophenolic Acid 1Hematopoietic Stem Cell Transplantation 1Cyclophosphamide 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Non-Malignant Neoplasm × Clear all
NCT04083183 2025-12-18

Total Body Irradiation and Astatine-211-Labeled BC8-B10 Monoclonal Antibody for the Treatment of Nonmalignant Diseases

Fred Hutchinson Cancer Center

Phase 1/2 Recruiting
40 enrolled
Other neoplasm

Non-Malignant Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡